Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
The Roles of Egr-2 in Autoimmune Diseases.
MicroRNA in neurodegenerative drug discovery: the way forward?
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
[Productivity and impact of Spanish research into multiple sclerosis (1996-2010)].
Neuropathic pain: diagnosis and treatment.
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells.
Simvastatin in patients with progressive multiple sclerosis.
Immune-mediated processes in neurodegeneration: where do we stand?
Inhibition of Epidermal Growth Factor Receptor Improves Myelination and Attenuates Tissue Damage of Spinal Cord Injury.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
Blood pressure normalization post-jugular venous balloon angioplasty.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis.
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response.

Pages